News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
772,871 Results
Type
Article (58701)
Company Profile (399)
Press Release (713771)
Section
Business (221462)
Career Advice (2935)
Deals (38094)
Drug Delivery (124)
Drug Development (87314)
Employer Resources (195)
FDA (17407)
Job Trends (16417)
News (375476)
Policy (36441)
Tag
2024 BioCapital Digital (15)
2024 BioForest Digital (9)
2024 BioForest Standard (1)
2024 BioMidwest Digital (11)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (13)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (12)
2024 Biotech Beach Standard (8)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (9)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (7)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2950)
Academic (2)
Accelerated approval (2)
Adcomms (28)
Allergies (88)
Alliances (54406)
ALS (93)
Alzheimer's disease (1465)
Antibody-drug conjugate (ADC) (134)
Approvals (17378)
Artificial intelligence (275)
Autoimmune disease (18)
Automation (14)
Bankruptcy (389)
Best Places to Work (12414)
BIOSECURE Act (19)
Biosimilars (114)
Biotechnology (259)
Bladder cancer (64)
Brain cancer (28)
Breast cancer (266)
Cancer (2135)
Cardiovascular disease (184)
Career advice (2468)
Career pathing (33)
CAR-T (157)
Cell therapy (437)
Cervical cancer (21)
Clinical research (70371)
Collaboration (834)
Compensation (462)
Complete response letters (28)
COVID-19 (2821)
CRISPR (43)
C-suite (231)
Cystic fibrosis (102)
Data (2010)
Decentralized trials (2)
Denatured (36)
Depression (48)
Diabetes (267)
Diagnostics (6809)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (122)
Drug pricing (119)
Drug shortages (31)
Duchenne muscular dystrophy (92)
Earnings (90584)
Editorial (39)
Employer branding (25)
Employer resources (165)
Events (122974)
Executive appointments (688)
FDA (18571)
Featured Employer (57)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (740)
Gene editing (109)
Generative AI (26)
Gene therapy (316)
GLP-1 (805)
Government (4911)
Grass and pollen (5)
Guidances (48)
Healthcare (20452)
Huntington's disease (24)
IgA nephropathy (25)
Immunology and inflammation (125)
Indications (27)
Infectious disease (2966)
Inflammatory bowel disease (145)
Inflation Reduction Act (11)
Influenza (50)
Intellectual property (91)
Interviews (563)
IPO (17271)
IRA (51)
Job creations (4467)
Job search strategy (2049)
Kidney cancer (10)
Labor market (37)
Layoffs (521)
Leadership (20)
Legal (9041)
Liver cancer (76)
Lung cancer (313)
Lymphoma (138)
Machine learning (4)
Management (64)
Manufacturing (294)
MASH (68)
Medical device (14276)
Medtech (14281)
Mergers & acquisitions (21297)
Metabolic disorders (708)
Multiple sclerosis (77)
NASH (23)
Neurodegenerative disease (102)
Neuropsychiatric disorders (30)
Neuroscience (2000)
NextGen: Class of 2025 (7286)
Non-profit (4958)
Northern California (2479)
Now hiring (38)
Obesity (385)
Opinion (259)
Ovarian cancer (75)
Pain (89)
Pancreatic cancer (79)
Parkinson's disease (144)
Partnered (20)
Patents (219)
Patient recruitment (97)
Peanut (51)
People (63043)
Pharmaceutical (105)
Pharmacy benefit managers (19)
Phase I (21809)
Phase II (30813)
Phase III (23120)
Pipeline (1078)
Podcasts (101)
Policy (134)
Postmarket research (3030)
Preclinical (9488)
Press Release (72)
Prostate cancer (99)
Psychedelics (38)
Radiopharmaceuticals (265)
Rare diseases (394)
Real estate (6790)
Recruiting (74)
Regulatory (24616)
Reports (56)
Research institute (2619)
Resumes & cover letters (462)
Rett syndrome (3)
RNA editing (4)
RSV (45)
Schizophrenia (75)
Series A (131)
Series B (83)
Service/supplier (18)
Sickle cell disease (57)
Southern California (2163)
Special edition (16)
Spinal muscular atrophy (160)
Sponsored (31)
Startups (4033)
State (2)
Stomach cancer (16)
Supply chain (66)
The Weekly (63)
United States (22267)
Vaccines (751)
Venture capitalists (39)
Webinars (13)
Weight loss (274)
Women's health (36)
Worklife (18)
Date
Today (147)
Last 7 days (761)
Last 30 days (2935)
Last 365 days (35574)
2025 (8647)
2024 (37334)
2023 (42277)
2022 (53494)
2021 (58216)
2020 (57055)
2019 (50435)
2018 (38284)
2017 (35332)
2016 (35537)
2015 (41637)
2014 (35745)
2013 (31154)
2012 (33192)
2011 (33819)
2010 (32465)
Location
Africa (992)
Alabama (51)
Alaska (7)
Arizona (247)
Arkansas (14)
Asia (45167)
Australia (7927)
California (5723)
Canada (1906)
China (505)
Colorado (259)
Connecticut (271)
Delaware (136)
Europe (99338)
Florida (840)
Georgia (206)
Hawaii (1)
Idaho (61)
Illinois (558)
India (26)
Indiana (308)
Iowa (9)
Japan (146)
Kansas (104)
Kentucky (25)
Louisiana (10)
Maine (60)
Maryland (880)
Massachusetts (4405)
Michigan (232)
Minnesota (393)
Mississippi (2)
Missouri (85)
Montana (31)
Nebraska (25)
Nevada (58)
New Hampshire (68)
New Jersey (1651)
New Mexico (31)
New York (1653)
North Carolina (1025)
North Dakota (8)
Northern California (2479)
Ohio (196)
Oklahoma (15)
Oregon (39)
Pennsylvania (1293)
Puerto Rico (10)
Rhode Island (28)
South America (1375)
South Carolina (19)
South Dakota (1)
Southern California (2163)
Tennessee (96)
Texas (860)
Utah (174)
Virginia (146)
Washington D.C. (65)
Washington State (543)
West Virginia (3)
Wisconsin (61)
772,871 Results for "sonoma pharmaceuticals formerly known as oculus innovative sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando
February 25, 2025
·
4 min read
Press Releases
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results
February 5, 2025
·
13 min read
Business
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network
NovaBay Pharmaceuticals, Inc. and Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) today announced an agreement for the sale and marketing of Avenova branded products by Sonoma in the European Union.
January 9, 2024
·
6 min read
Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) today announced that it will be presenting at two upcoming investor conferences in Denver and New York.
March 28, 2024
·
4 min read
Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores
Sonoma Pharmaceuticals, Inc. today announced the launch of its MicrocynAH animal health care products in the Menards chain of home improvement stores in the United States.
May 9, 2024
·
4 min read
Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States
Sonoma Pharmaceuticals, Inc. today announced the expansion of its Microcyn Negative-Pressure Wound Therapy (NPWT) Solution products in the United States.
April 9, 2024
·
4 min read
Business
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results
Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA),a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications including wound, eye, oral and nasal care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants, today announced financial results for fiscal year 2024 and the fourth quarter ended March 31, 2024.
June 17, 2024
·
11 min read
Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections
Sonoma Pharmaceuticals, Inc. reported a recent publication in the journal Neurourology and Urodynamics highlighting the potential for Microdox in the management of urinary tract infections.
April 4, 2024
·
5 min read
Press Releases
Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)
March 11, 2025
·
3 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
1 of 77,288
Next
